Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival

Journal of Cardiovascular Magnetic Resonance

Michael A Gatzoulis¹  Konstantinos Dimopoulos¹  Sonya V Babu-Narayan³  Chad Carr²  Sanjay K Prasad³  Craig S Broberg² 

[1] Adult Congenital Heart Disease Centre and National Centre for Pulmonary Hypertension, NIHR Cardiovascular BRU, and the National Heart & Lung Institute, Imperial College, London, UK;Adult Congenital Heart Program, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA;NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, Imperial College, London, UK

关键词: Cardiovascular magnetic resonance;    Myocardial fibrosis;    Pulmonary artery hypertension;    Cyanosis;    Eisenmenger;   

Others  :  801287
DOI  :  10.1186/1532-429X-16-32

 received in 2013-12-16, accepted in 2014-05-02,  发布年份 2014

【 摘 要 】

Background

A relationship between myocardial fibrosis and ventricular dysfunction has been demonstrated using late gadolinium enhancement (LGE) in the pressure-loaded right ventricle from congenital heart defects. In patients with Eisenmenger syndrome (ES), the presence of LGE has not been investigated. The aims of this study were to detect any myocardial fibrosis in ES and describe major clinical variables associated with the finding.

Methods

From 45 subjects screened, 30 subjects (age 43 ± 13 years, 20 female) underwent prospective cardiovascular magnetic resonance with LGE to quantify biventricular volume and function as well as maximal and submaximal exercise during a single visit. Standard cine acquisitions were obtained for ventricular volume and function. Further imaging was performed after administration of 0.1 mmol/kg gadolinium contrast. Regions of LGE were evaluated qualitatively and quantitatively by manual contouring of identified areas, with total area expressed as a percentage of mass. Patients were followed prospectively (mean follow up 7.4 ± 0.4 years) and any deaths recorded. Patients with LGE findings were compared to those without.

Results

LGE was present in 22/30 (73%) patients, specifically in RV myocardium (70%), RV trabeculae (60%), LV myocardium (33%) or LV papillary muscles (30%), though in small amounts (mean 1.4% of total ventricular mass, range 0.16 – 6.0%). Those with any LGE were not different in age, history of arrhythmia, desaturation, nor hemoglobin, nor ventricular size, mass, or function. Exercise capacity was low, but also not different between those with and without LGE. Similarly no significant associations were found with amount of fibrosis. There were five deaths among patients with LGE, versus two in patients without, but no difference in survival (log rank =0.03, P = 0.85).

Conclusions

Myocardial fibrosis by LGE is common in ES, though not extensive. The presence and quantity of LGE did not correlate with ventricular size, function, degree of cyanosis, exercise capacity, or survival in this pilot study. More data are clearly required before recommendations for routine use of LGE in these patients can be made.

【 授权许可】

   
2014 Broberg et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA: Presentation, survival prospects, and predictors of death in ES: a combined retrospective and case–control study. Eur Heart J 2006, 27:1737-42. Epub 2006 Jun 1722
• [2]Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S: The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 2009, 54:1407-24.
• [3]Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ, Gatzoulis MA, Kilner PJ: Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation 2005, 111:2091-8.
• [4]Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA: Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation 2006, 113:405-13.
• [5]Rathod RH, Prakash A, Powell AJ, Geva T: Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol 2010, 55:1721-8.
• [6]Wald RM, Haber I, Wald R, Valente AM, Powell AJ, Geva T: Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation 2009, 119:1370-7.
• [7]Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA: Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002, 106:92-9.
• [8]Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M: Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 2010, 3:727-34.
• [9]Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, Davidson SJ, Uebing A, Khan AA, Thein S, Gibbs JS, Burman J, Gatzoulis MA: Blood viscosity and its relation to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 2006, 48:356-65.
• [10]Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, Davidson SJ, Bouzas B, Gibbs JS, Burman J, Gatzoulis MA: Pulmonary arterial thrombosis in ES is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 2007, 50:634-42.
• [11]Bradlow WM, Assomull R, Kilner PJ, Gibbs JS, Sheppard MN, Mohiaddin RH: Understanding late gadolinium enhancement in pulmonary hypertension. Circ Cardiovasc Imaging 2010, 3:501-3.
• [12]Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982, 284:1607-8.
• [13]Hartke LP, Gilkeson RC, O'Riordan MA, Siwik ES: Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions. Congenit Heart Dis 2006, 1:192-201.
• [14]Buchhorn R, Ross RD, Bartmus D, Wessel A, Hulpke-Wette M, Bursch J: Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts. Int J Cardiol 2001, 78:225-30. discussion 230–221
• [15]Cohn JN: Myocardial structural effects of aldosterone receptor antagonism in heart failure. J Am Coll Cardiol 2007, 50:597-9.
• [16]Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA: Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005, 112:828-35.
• [17]Diller GP, Alonso-Gonzalez R, Kempny A, Dimopoulos K, Inuzuka R, Giannakoulas G, Castle L, Lammers AE, Hooper J, Uebing A, Swan L, Gatzoulis M, Wort SJ: B-type natriuretic peptide concentrations in contemporary ES patients: predictive value and response to disease targeting therapy. Heart 2012, 98:736-42.
• [18]Bradlow WM, Gibbs JS, Mohiaddin RH: Cardiovascular magnetic resonance in pulmonary hypertension. J Cardiovasc Magn Reson 2012, 14:6. BioMed Central Full Text
• [19]Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA: Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008, 117:2320-8.